Item 2.01. Completion of Acquisition or Disposition of Assets.
On
• Catheter's Unaudited Financial Statements as of and for the nine months endedSeptember 30, 2022 andSeptember 30, 2021 ; • Unaudited Pro Forma Condensed Combined Financial Information related to the Merger as of and for the nine months endedSeptember 30, 2022 and for the year endedDecember 31, 2021 ; and • Catheter's Management's Discussion and Analysis as of and for the nine months endedSeptember 30, 2022 andSeptember 30, 2021 .
Additional Information and Where to Find It
This communication relates to the possible conversion of securities issued in
the Merger, and the issuance of securities in private placements, and may be
deemed to be solicitation material in respect of the stockholder approval
thereof. In connection with the proposed approval of those conversions, the
Company will file a Proxy Statement with the
This communication shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
The unaudited pro forma combined financial information does not purport to represent the actual results of operations that the Company and Catheter would have achieved had the companies been combined during the periods presented in the unaudited pro forma combined financial statements and is not intended to project the future results of operations that the combined company may achieve after the Merger. The unaudited pro forma combined financial information does not reflect any potential cost savings that may be realized as a result of the Merger and also does not reflect any restructuring or integration-related costs to achieve those potential cost savings. This communication shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
--------------------------------------------------------------------------------
Participants in the Solicitation
Catheter, the Company, and their respective directors and executive officers may
be deemed to be participants in the solicitation of proxies from the
stockholders of the Company in connection with the proposed securities
conversions and other proposals. Information about the Company's directors and
executive officers is set forth in the Company's Current Report on Form 8-K that
was filed with the
--------------------------------------------------------------------------------
Item 9.01. Financial Statements and Exhibits.
(a) Financial statements of business acquired.
The unaudited financial statements of Catheter as of and for the nine months
ended
(b) Pro forma financial information.
The unaudited pro forma condensed combined financial information of
(d) Exhibits Exhibit Description 99.1 Unaudited financial statements of Catheter as of and for the nine months endedSeptember 30, 2022 andSeptember 30, 2021 , with the accompanying notes. 99.2 Unaudited pro forma condensed combined financial information ofRa Medical and Catheter as of and for the nine months endedSeptember 30, 2022 and for the year endedDecember 31, 2021 , with the accompanying notes. 99.3 Management's Discussion and Analysis of Catheter as of and for the nine months endedSeptember 30, 2022 andSeptember 30, 2021 . 104 Cover Page Interactive Data File (formatted as inline XBRL)
--------------------------------------------------------------------------------
© Edgar Online, source